13 results
8-K
EX-99.2
AKRO
Akero Therapeutics Inc
5 Jun 23
Results of Operations and Financial Condition
8:05am
for the development of medicinal products ©2023 AKERO THERAPEUTICS. 11 Liver Fibrosis: Developing Drugs for Treatment (2018) for chronic non-infectious
8-K
EX-99.2
AKRO
Akero Therapeutics Inc
13 Sep 22
Regulation FD Disclosure
9:07am
products for chronic non-infectious liver diseases (PBC, PSC, NASH) (2018)
Week 24 Patient Disposition & Analysis Sets ©2022 AKERO THERAPEUTICS
8-K
EX-99.1
dk5buwsfcm
13 May 20
Akero Therapeutics Reports first Quarter 2020 Financial Results
4:17pm
10-K
shga11p8b ks0byu35
16 Mar 20
Annual report
5:17pm
424B4
w97pisyf r4lklxx5fj7
20 Jun 19
Prospectus supplement with pricing info
5:20pm
S-1/A
yc8 6wwdwck
10 Jun 19
IPO registration (amended)
11:16am
S-1
fuc660uox2k y3
24 May 19
IPO registration
4:18pm
DRS/A
28lr41h0zp ivy
30 Apr 19
Draft registration statement (amended)
12:00am
DRS/A
ppe8rnef5nn06prys
19 Mar 19
Draft registration statement (amended)
12:00am
DRS
dmjxr5
17 Jan 19
Draft registration statement
12:00am
- Prev
- 1
- Next